CVS Health Stock Pops as Q4 Sales, Earnings Top Estimates

Shares of CVS Health ( CVS ) surged Wednesday morning after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results.

CVS reported adjusted earnings per share (EPS) of $1.19 on revenue of $97.71 billion. Analysts polled by Visible Alpha expected adjusted EPS of $0.91 on revenue of $96.89 billion.

CVS shares were up over 14% shortly after the market opened Wednesday. They entered the day down about 28% over the past 12 months.

Looking ahead to 2025, CVS said it expects adjusted EPS between $5.75 to $6.00, up from the $5.42 it registered in 2024. Analysts were looking for $5.90.

"We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits segment," new CEO David Joyner said.

The results cap a tumultuous quarter for CVS, which saw the company replace its CEO in October , weeks after reports emerged that it was considering separating its retail pharmacies and Aetna health insurance operations amid struggling results and pressure from investors.

UPDATE—This article has been updated with the latest share price information and CVS' 2025 projections.

Read the original article on Investopedia